0001209191-23-030581.txt : 20230518
0001209191-23-030581.hdr.sgml : 20230518
20230518160233
ACCESSION NUMBER: 0001209191-23-030581
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230516
FILED AS OF DATE: 20230518
DATE AS OF CHANGE: 20230518
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: STEPHENSON BRIAN C
CENTRAL INDEX KEY: 0001780030
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38959
FILM NUMBER: 23935996
MAIL ADDRESS:
STREET 1: 3160 PORTER DR, STE 250
CITY: PALO ALTO
STATE: CA
ZIP: 94304
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BridgeBio Pharma, Inc.
CENTRAL INDEX KEY: 0001743881
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3160 PORTER DR.
STREET 2: SUITE 250
CITY: PALO ALTO
STATE: CA
ZIP: 94304
BUSINESS PHONE: (650) 391-9740
MAIL ADDRESS:
STREET 1: 3160 PORTER DR.
STREET 2: SUITE 250
CITY: PALO ALTO
STATE: CA
ZIP: 94304
FORMER COMPANY:
FORMER CONFORMED NAME: BridgeBio Pharma LLC
DATE OF NAME CHANGE: 20180618
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-05-16
0
0001743881
BridgeBio Pharma, Inc.
BBIO
0001780030
STEPHENSON BRIAN C
C/O BRIDGEBIO PHARMA, INC.
3160 PORTER DR., SUITE 250
PALO ALTO
CA
94304
0
1
0
0
Secretary, Treasurer & CFO
1
Common Stock
2023-05-16
4
M
0
44996
A
81404
D
Common Stock
2023-05-16
4
F
0
20572
14.09
D
60832
D
Common Stock
2023-05-17
4
S
0
24424
14.0095
D
36408
D
Restricted Stock Units
2023-05-16
4
M
0
1710
0.00
D
Common Stock
1710
6839
D
Restricted Stock Units
2023-05-16
4
M
0
778
0.00
D
Common Stock
778
5447
D
Restricted Stock Units
2023-05-16
4
M
0
24193
0.00
D
Common Stock
24193
72579
D
Restricted Stock Units
2023-05-16
4
M
0
947
0.00
D
Common Stock
947
9465
D
Restricted Stock Units
2023-05-16
4
M
0
17368
0.00
D
Common Stock
17368
260525
D
Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
Represents the number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the vesting of 44,996 shares of Common Stock underlying the Reporting Person's RSUs.
This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on December 6, 2022.
Represents the weighted average sale price of the shares sold from $13.83 to $14.22 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions as reported herein.
The RSUs vest in sixteen quarterly installments after May 16, 2020, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date.
The RSUs vest in sixteen quarterly installments after February 16, 2021, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date.
The RSUs vest with respect to 1/8th of the underlying shares on May 16, 2022. Thereafter, 1/8th of the underlying shares shall vest on a quarterly basis, so that all of the underlying shares shall be vested on February 16, 2024, subject to the Reporting Person's continued service to the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date.
The RSUs vest with respect to 25% of the underlying shares on November 16, 2022. Thereafter, 1/12th of the remaining underlying shares shall vest on a quarterly basis, so that all of the underlying shares shall be vested on November 16, 2025, subject to the Reporting Person's continued service to the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date.
The RSUs vest with respect to 1/16th of the underlying shares on May 16, 2023. Thereafter, 1/16th of the underlying shares shall vest on a quarterly basis, such that all of the underlying shares shall be vested on February 16, 2027, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date.
/s/ Brian C. Stephenson
2023-05-18